Glenmark Pharmaceuticals (NSE:GLENMARK) Issuance of Debt : ₹0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals Issuance of Debt?

Glenmark Pharmaceuticals's Issuance of Debt for the three months ended in Sep. 2024 was ₹0 Mil.

Glenmark Pharmaceuticals's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil.

Glenmark Pharmaceuticals Issuance of Debt Historical Data

The historical data trend for Glenmark Pharmaceuticals's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals Issuance of Debt Chart

Glenmark Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Issuance of Debt

Get a 7-Day Free Trial

8,450.64

17,298.60

21,300.57

11,631.90

4,811.20

Glenmark Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Issuance of Debt	Get a 7-Day Free Trial															-	-	-	-	-

Glenmark Pharmaceuticals Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Glenmark Pharmaceuticals Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Glenmark Pharmaceuticals's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Glenmark Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (NSE:GLENMARK) » Definitions » Issuance of Debt

Traded in Other Exchanges

532296:India

Address

B. D. Sawant Marg, Glenmark House, Chakala, Off Western Express Highway, Andheri (East), Mumbai, MH, IND, 400099

Website

https://www.glenmarkpharma.com

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe, and the rest of the world.

Glenmark Pharmaceuticals Headlines

No Headlines